Literature DB >> 11482708

Diagnostic value of resting tricuspid regurgitation velocity and right ventricular ejection flow parameters for the detection of exercise induced pulmonary arterial hypertension.

E Bossone1, E Avelar, D S Bach, B Gillespie, M Rubenfire, W F Armstrong.   

Abstract

UNLABELLED: Our objectives were to evaluate resting tricuspid regurgitation velocity (TRV) and right ventricular outflow tract velocity curve (RVOTvc) profiles as markers for development of exercise induced pulmonary arterial hypertension (ExPHT). ExPHT is an elusive cause of dyspnea and fatigue. When present, Doppler echocardiography can detect and quantify elevated pulmonary pressure. However, the characteristics and diagnostic value of resting TRV and RVOTvc indices in patients with ExPHT have not been fully addressed. The study population consisted of 52 subjects (mean age 40.5 +/- 10.9, range 22-68 years) and was divided into three subsets as follows: 1. Patients (n = 22) with overt pulmonary hypertension (PHT), 2. Patients (n = 8) with ExPHT, 3. Healthy, asymptomatic volunteers (n = 22). RVOTvc indices included: Mean and peak velocity, systolic velocity time integral (VTI); velocity time integral at peak velocity (VTImax), acceleration time; ejection time. TRV was used as an index of pulmonary artery systolic pressure. There were significant differences between normals and ExPHT for TRV, acceleration time, VTI(Vmax). TRV and VTImax were predictive of EXPHT in a logistic regression model.
CONCLUSION: (1) Patients with ExPHT have distinct Doppler velocity patterns suggesting the presence of a compromised pulmonary vascular bed even with normal pulmonary pressure at rest. (2) TRV and RVOTvc indices have potential diagnostic value in the early detection of ExPHT.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11482708     DOI: 10.1023/a:1010604913656

Source DB:  PubMed          Journal:  Int J Card Imaging        ISSN: 0167-9899


  20 in total

1.  Noninvasive evaluation of pulmonary artery systolic pressures during dynamic exercise by saline-enhanced Doppler echocardiography.

Authors:  R B Himelman; M S Stulbarg; E Lee; H F Kuecherer; N B Schiller
Journal:  Am Heart J       Date:  1990-03       Impact factor: 4.749

2.  Comparison of three Doppler ultrasound methods in the prediction of pulmonary artery pressure.

Authors:  K L Chan; P J Currie; J B Seward; D J Hagler; D D Mair; A J Tajik
Journal:  J Am Coll Cardiol       Date:  1987-03       Impact factor: 24.094

3.  Evaluation of pulmonary artery pressure and resistance by pulsed Doppler echocardiography.

Authors:  A Dabestani; G Mahan; J M Gardin; K Takenaka; C Burn; A Allfie; W L Henry
Journal:  Am J Cardiol       Date:  1987-03-01       Impact factor: 2.778

Review 4.  Primary pulmonary hypertension.

Authors:  L J Rubin
Journal:  Chest       Date:  1993-07       Impact factor: 9.410

5.  Echocardiographic features of primary pulmonary hypertension.

Authors:  E Bossone; T H Duong-Wagner; G Paciocco; H Oral; M Ricciardi; D S Bach; M Rubenfire; W F Armstrong
Journal:  J Am Soc Echocardiogr       Date:  1999-08       Impact factor: 5.251

6.  Range of tricuspid regurgitation velocity at rest and during exercise in normal adult men: implications for the diagnosis of pulmonary hypertension.

Authors:  E Bossone; M Rubenfire; D S Bach; M Ricciardi; W F Armstrong
Journal:  J Am Coll Cardiol       Date:  1999-05       Impact factor: 24.094

7.  Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound.

Authors:  M Berger; A Haimowitz; A Van Tosh; R L Berdoff; E Goldberg
Journal:  J Am Coll Cardiol       Date:  1985-08       Impact factor: 24.094

8.  Noninvasive evaluation of pulmonary artery pressure during exercise by saline-enhanced Doppler echocardiography in chronic pulmonary disease.

Authors:  R B Himelman; M Stulbarg; B Kircher; E Lee; L Kee; N C Dean; J Golden; C L Wolfe; N B Schiller
Journal:  Circulation       Date:  1989-04       Impact factor: 29.690

9.  Noninvasive evaluation of pulmonary hypertension by a pulsed Doppler technique.

Authors:  A Kitabatake; M Inoue; M Asao; T Masuyama; J Tanouchi; T Morita; M Mishima; M Uematsu; T Shimazu; M Hori; H Abe
Journal:  Circulation       Date:  1983-08       Impact factor: 29.690

10.  Pulsed Doppler echocardiography in the diagnosis of pulmonary hypertension in COPD.

Authors:  M Miguéres; R Escamilla; F Coca; A Didier; M Krempf
Journal:  Chest       Date:  1990-08       Impact factor: 9.410

View more
  7 in total

1.  Effect of simulated diving trips on pulmonary artery pressure in healthy men.

Authors:  Jochen Hansel; Christof Burgstahler; Sabine Medler; Detlef Axmann; Andreas M Niess; Kay Tetzlaff
Journal:  Clin Res Cardiol       Date:  2012-06-14       Impact factor: 5.460

2.  Assessment of hemodynamic changes in the systemic and pulmonary arterial circulation in patients with cystic fibrosis using phase-contrast MRI.

Authors:  Sebastian Ley; Michael Puderbach; Christian Fink; Monika Eichinger; Christian Plathow; Susanne Teiner; Matthias Wiebel; Frank-Michael Müller; Hans-Ulrich Kauczor
Journal:  Eur Radiol       Date:  2005-03-11       Impact factor: 5.315

3.  Three-wall segment (TriSeg) model describing mechanics and hemodynamics of ventricular interaction.

Authors:  Joost Lumens; Tammo Delhaas; Borut Kirn; Theo Arts
Journal:  Ann Biomed Eng       Date:  2009-08-29       Impact factor: 3.934

Review 4.  Pulmonary hypertension: current diagnosis and treatment.

Authors:  Stephan Rosenkranz
Journal:  Clin Res Cardiol       Date:  2007-06-04       Impact factor: 5.460

5.  A novel expression of exercise induced pulmonary hypertension in human immunodeficiency virus patients: a pilot study.

Authors:  Rami Doukky; Won Y Lee; Mahindhar Ravilla; Omar B Lateef; Victor Pelaez; Audrey French; Rajive Tandon
Journal:  Open Cardiovasc Med J       Date:  2012-04-20

6.  PKC translocation and ERK1/2 activation in compensated right ventricular hypertrophy secondary to chronic emphysema.

Authors:  Erick Avelar; Thunder Jalili; Li Dong; Joel Arvizo; Ping Hu; Sheldon E Litwin; John P Mattson
Journal:  BMC Physiol       Date:  2005-05-05

7.  Long-term results of treatment with bosentan in adult Eisenmenger's syndrome patients with Down's syndrome related to congenital heart disease.

Authors:  Roberto Crepaz; Cristina Romeo; Donato Montanaro; Stefano De Santis
Journal:  BMC Cardiovasc Disord       Date:  2013-09-18       Impact factor: 2.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.